Crown Aesthetics, a division of Crown Laboratories and the leader in minimally invasive aesthetic treatments, announced that the British Standards Institution (BSI) has awarded a Class IIa CE Certification mark to SkinPen Precision. The certification confirms SkinPen as a treatment to improve the appearance of facial acne scars in adults aged 22 years or older and to improve the appearance of fine lines and wrinkles on the face and neck. The SkinPen is also intended to treat pigmentation conditions (dyschromia) including melasma, vitiligo, and solar lentigines. "This new and expanded certification further validates SkinPen's safety and usage claims in the EU," says Joe Proctor, president of Crown Aesthetics. "With SkinPen's advanced microneedling technology, we continue to set a higher standard in patient care, and firmly establishes the industry benchmark for safety. This essential certification allows us to continue offering best in class technology to our physician partners and their patients and solidifies the company's growing presence in the global market."
RELATED STORIES
Crown Laboratories Completes Commercial Integration Plan
AAFPRS Sees A Spike In Requests For Aesthetic Treatments
Toronto’s Midtown Med Spa Is First To Offer Cutera's TruSculpt Flex